期刊文献+

持续静脉滴注奥曲肽防治重症急性胰腺炎并发症

Octreotide reduces the complications of severe acute pancreatitis(SAP) patients
原文传递
导出
摘要 目的观察奥曲肽对重症急性胰腺炎(SAP)并发症的防治作用.方法将68例SAP住院患者随机分为治疗组(n=36)及对照组(n=32),两组均采用传统的内科保守疗法,但治疗组加用奥曲肽50 μg/h,持续静脉滴注8~10 d,比较两组病例发生胸腔积液、肺炎、高血糖、假性胰腺囊肿的情况.结果治疗组胸腔积液、肺炎、高血糖、假性胰腺囊肿等并发症发生率明显低于对照组(P<0.05).结论奥曲肽可降低SAP并发症发生率,减少外科手术的机会. Objective To explore the prevertion and care effect of octreotide on complications of SAP. Methods Sixty-eight cases with SAP were divided into therapeutic group(n=36) and control group(n=32) randomly.All cases of two groups accepted conventional therapy. Therpeutic group accepted intra-venous octreotide therapy(50μg/h) for 8 to 10 days in addition. The complications of pleural effusion, pneumonia, hyperglycemia, pseudocyst of prancrease between the two groups were compared. Results The complications of pleural effusion,pneumonia, hyperglycemia, pseudocyst of prancrease in therapeutic were significantly lower than that in contrast group(P〈0.05).Conclusion The application of octreotide in SAP patients declines the complications of pleural effusion ,pneumonia hyperglycemia,pseudocgst of pancrease and chance of surgical therapy.
出处 《中国基层医药》 CAS 2005年第7期794-795,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 持续静脉滴注 奥曲肽 防治 急性胰腺炎 并发症 Pancreatitis, acute necrotizing Octreotide Complication
  • 相关文献

参考文献5

二级参考文献28

  • 1中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 2Zazzo JF. Schweiz Med Wochenschr, 1999; 129(43): 1617-1625
  • 3Davies MG et al. BrJ Surg,1997;84(7):920
  • 4Shimada H et al. Nippon Geka Gakkai Zasshi,1998;99(8):490
  • 5Chen X et al. Pancreas,1999;18(1): 39-46
  • 6Luiten KJ et al. Ann Surg, 1995;222(1): 57-65
  • 7Kong SE et al. Anal Bilehem, 1999;271(1):111-114
  • 8Foiitzik T et al. J Gastmintest Surg, 1997;1(1):40-47
  • 9Colak T et al. Stag Toclay,2001; 31(6):502-506
  • 10Mangiante G et al. Dig Surg,2001;18(1):47-50

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部